Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Gupta

Showing results (871-880 of 894) with videos related to

Pageof 90
Sort By:
Lancet (London, England)|June 18, 2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial, Haleema Shakur, Ian Roberts, et al.
Transboundary and Emerging Diseases|January 10, 2020
Serological surveillance and clinical investigation of glanders among indigenous equines in India from 2015 to 2018Harisankar Singha, Karuppusamy Shanmugasundaram, Bhupendra Nath Tripathi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinomaAwalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Journal of Critical Care|March 16, 2024
Assessment of the comparative agreement between chest radiographs and CT scans in intensive care unitsDaniel Brooks, Stephen E Wright, Anna Beattie, et al.
Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
NPJ Precision Oncology|May 4, 2021
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site studyPatrick Leo, Andrew Janowczyk, Robin Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.
Scientific Reports|June 15, 2017
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialSurendra K Sharma, Kiran Katoch, Rohit Sarin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2025
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trialBruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, et al.
Pageof 90

Showing results (871-880 of 894) with videos related to

Sort By:
Pageof 90
Lancet (London, England)|June 18, 2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial, Haleema Shakur, Ian Roberts, et al.
Transboundary and Emerging Diseases|January 10, 2020
Serological surveillance and clinical investigation of glanders among indigenous equines in India from 2015 to 2018Harisankar Singha, Karuppusamy Shanmugasundaram, Bhupendra Nath Tripathi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinomaAwalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Journal of Critical Care|March 16, 2024
Assessment of the comparative agreement between chest radiographs and CT scans in intensive care unitsDaniel Brooks, Stephen E Wright, Anna Beattie, et al.
Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
NPJ Precision Oncology|May 4, 2021
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site studyPatrick Leo, Andrew Janowczyk, Robin Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.
Scientific Reports|June 15, 2017
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialSurendra K Sharma, Kiran Katoch, Rohit Sarin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2025
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trialBruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, et al.
Pageof 90